Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to 0.76.

  • Nephros' Equity Ratio fell 402.53% to 0.76 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.76, marking a year-over-year decrease of 402.53%. This contributed to the annual value of 0.77 for FY2024, which is 868.1% up from last year.
  • Per Nephros' latest filing, its Equity Ratio stood at 0.76 for Q3 2025, which was down 402.53% from 0.78 recorded in Q2 2025.
  • In the past 5 years, Nephros' Equity Ratio registered a high of 0.87 during Q1 2021, and its lowest value of 0.7 during Q4 2023.
  • Over the past 5 years, Nephros' median Equity Ratio value was 0.81 (recorded in 2022), while the average stood at 0.8.
  • Its Equity Ratio has fluctuated over the past 5 years, first skyrocketed by 1621.53% in 2021, then plummeted by 1431.35% in 2024.
  • Over the past 5 years, Nephros' Equity Ratio (Quarter) stood at 0.84 in 2021, then fell by 3.37% to 0.81 in 2022, then fell by 12.73% to 0.7 in 2023, then rose by 8.68% to 0.77 in 2024, then fell by 1.37% to 0.76 in 2025.
  • Its Equity Ratio was 0.76 in Q3 2025, compared to 0.78 in Q2 2025 and 0.79 in Q1 2025.